Article Information
History
- September 30, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Author Information
- Enriqueta Vallejo-Yagüe1,
- Theresa Burkard1,
- Axel Finckh2,
- Andrea M. Burden1,3,* and
- the clinicians and patients of the Swiss Clinical Quality Management Program
- 1Pharmacoepidemiology Group, Institute of Pharmaceutical Sciences, Department of Chemistry and Applied Biosciences, ETH Zurich, Zurich, Switzerland
- 2Division of Rheumatology, University Hospitals Geneva, Geneva, Switzerland
- 3Clinical Pharmacology and Toxicology, University Hospital Zurich, University of Zurich, Zurich, Switzerland
- ↵*Correspondence to:
Andrea M. Burden E-mail address: andrea.burden{at}pharma.ethz.ch Telephone number +41 44 633 74 09
Posted September 30, 2022.
Comparative effectiveness of biologics in patients with rheumatoid arthritis stratified by body mass index and sex: a cohort study in SCQM
